Janux Therapeutics, Inc.
JANX
11 insider filings · Latest: Jul 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | Oct 21 8:25 PM | Reardon Tighe | Proposed Sale | 6,324 | $50.21 | $317.5K | — | View → |
| Oct 21, 2024 | Oct 21 5:39 PM | Lichter Jay | Proposed Sale | 2,434 | $49.49 | $120.5K | — | View → |
| Oct 18, 2024 | Oct 18 8:57 PM | Avalon Ventures XI, L.P. | Proposed Sale | 118,194 | $50.38 | $6.0M | — | View → |
| Oct 18, 2024 | Oct 18 8:48 PM | Avalon BioVentures I, LP | Proposed Sale | 22,895 | $50.38 | $1.2M | — | View → |
| Oct 18, 2024 | Oct 18 8:39 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 120,680 | $50.38 | $6.1M | — | View → |
| Oct 17, 2024 | Oct 17 9:06 PM | Reardon Tighe | Proposed Sale | 8,158 | $50.01 | $408.0K | — | View → |
| Oct 17, 2024 | Oct 17 8:24 PM | Lichter Jay | Proposed Sale | 1,842 | $50.05 | $92.2K | — | View → |
| Oct 17, 2024 | Oct 17 8:18 PM | Reardon Tighe | Proposed Sale | 4,784 | $49.67 | $237.6K | — | View → |
| Oct 16, 2024 | Oct 16 10:14 PM | Reardon Tighe | Proposed Sale | 48,462 | $50.78 | $2.5M | — | View → |
| Oct 16, 2024 | Oct 16 9:35 PM | Avalon BioVentures I, LP | Proposed Sale | 17,367 | $49.96 | $867.6K | — | View → |
| Oct 16, 2024 | Oct 16 9:28 PM | Lichter Jay | Proposed Sale | 10,957 | $50.80 | $556.6K | — | View → |
| Oct 16, 2024 | Oct 16 9:25 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 91,539 | $49.96 | $4.6M | — | View → |
| Oct 16, 2024 | Oct 16 9:17 PM | Avalon Ventures XI, L.P. | Proposed Sale | 89,653 | $49.96 | $4.5M | — | View → |
| Oct 16, 2024 | Oct 16 9:10 PM | Reardon Tighe | Proposed Sale | 28,993 | $51.34 | $1.5M | — | View → |
| Sep 30, 2024 | Sep 30 9:34 PM | Lichter Jay | Proposed Sale | 958 | $46.24 | $44.3K | — | View → |
| Sep 30, 2024 | Sep 30 9:29 PM | Reardon Tighe | Proposed Sale | 4,493 | $46.61 | $209.4K | — | View → |
| Sep 30, 2024 | Sep 30 8:08 PM | Reardon Tighe | Proposed Sale | 2,537 | $46.04 | $116.8K | — | View → |
| Sep 27, 2024 | Sep 27 10:31 PM | Reardon Tighe | Proposed Sale | 7,812 | $45.92 | $358.8K | — | View → |
| Sep 27, 2024 | Sep 27 9:05 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 48,403 | $46.43 | $2.2M | — | View → |
| Sep 27, 2024 | Sep 27 8:54 PM | Lichter Jay | Proposed Sale | 1,826 | $46.19 | $84.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Jul 11 12:00 AM | Campbell David AlanDirector, President and CEO | Option Exercise | 7,000 | $4.21 | 697,550(D) | View → |
| Jun 11, 2026 | Jun 13 12:30 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 15,500 | $13.66 | 15,500(I) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Jake SimsonDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Winston KungDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Natasha HerndayDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Eric DobmeierDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Vickie L CappsDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Ronald W BarrettDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Feb 2, 2026 | Feb 5 1:01 AM | William GoChief Medical Officer | Grant/Award | 154,000 | $13.99 | 154,000(D) | View → |